The chemistry of the antibiotics chrysomycin A and B. Antitumor activity of chrysomycin A.

The yellow antibiotic chrysomycin, isolated in crystalline form in 1955, is found to consist of two closely related components, a major one, chrysomycin A, and a minor one, chrysomycin B. They differ only through the replacement of a vinyl group of chrysomycin A by methyl in chrysomycin B. The absorption spectrum of chrysomycin A is identical with that of the antitumor antibiotic toromycin (gilvocarcin V, 2064A), while that of chrysomycin B is similarly identical with the one of gilvocarcin M (2064B). The structures of these antibiotics (toromycin, the glivocarcins, and 2064A and B) have been elucidated recently. Chrysomycins A and B thus contain the same chromophores as gilvocarcins V and M, respectively; comparison of 1H and 13C NMR spectra confirms this identity. The chrysomycins differ from these other antibiotics in the C-glycosidic side-chain, which is a methylpentose in the gilvocarcins, a 3,5-dimethylpentose in the chrysomycins. Structure and relative configuration of the latter are given. The biological activity and possible biosynthesis of the chrysomycins are discussed.

[1]  P. Roller,et al.  Detection of gilvocarcin antitumor complex by a biochemical induction assay (BIA). , 1982, The Journal of antibiotics.

[2]  J. Clardy,et al.  Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E. , 1981, The Journal of antibiotics.

[3]  J. Findlay,et al.  The structure of ravidomycin , 1981 .

[4]  M. Morimoto,et al.  Gilvocarcins, new antitumor antibiotics. 3. Antitumor activity. , 1981, The Journal of antibiotics.

[5]  HirayamaNoriaki,et al.  Crystal and molecular structure of antibiotic gilvocarcin M. , 1981 .

[6]  F. Tomita,et al.  Gilvocarcins, new antitumor antibiotics. 2. Structural elucidation. , 1981, The Journal of antibiotics.

[7]  K. Hatano,et al.  Chemistry of Toromycin , 1980 .

[8]  J. Yoshimura,et al.  Synthesis of methyl .BETA.-D-virenoside. , 1980 .

[9]  M. Yarmolinsky,et al.  A colorimetric assay of lysogenic induction designed for screening potential carcinogenic and carcinostatic agents. , 1979, Environmental mutagenesis.

[10]  M. Tanabe,et al.  Utilization of 13C–13C coupling in structural and biosynthetic studies; the Fourier transform 13C nuclear magnetic resonance spectrum of mollisin , 1973 .

[11]  T. Devon,et al.  Handbook of naturally occurring compounds , 1972 .

[12]  R. Geran,et al.  PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS , 1972 .

[13]  J. R. Brown,et al.  Biosynthesis of the aglycone of chartreusin in Streptomyces sp. X-465 , 1971 .

[14]  M. Tanabe,et al.  Biosynthetic studies with carbon-13: mollisin. , 1970, Biochemistry.

[15]  L. Mitscher,et al.  The structural characterization of tetrangomycin and tetrangulol. , 1966, The Journal of organic chemistry.

[16]  S. Gatenbeck,et al.  Naphthoquinone biosynthesis in molds. The mechanism for formation of mollisin. , 1965, Biochemistry.

[17]  H. Schmid,et al.  Über die Struktur des Chartreusins I , 1964 .

[18]  K. Mosbach,et al.  The mechanism of biosynthesis of citromycetin. , 1963, Biochemical and biophysical research communications.

[19]  F. Strelitz,et al.  CHRYSOMYCIN: A NEW ANTIBIOTIC SUBSTANCE FOR BACTERIAL VIRUSES , 1955, Journal of bacteriology.

[20]  E. Hall,et al.  A survey of actinomycetes for antiphage activity. , 1954, Antibiotics & chemotherapy.